Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Trypsinogen

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Propanc Biopharma Files 4th Provisional Patent in 2 Months
    Propanc Biopharma Files 4th Provisional Patent in 2 Months

    27 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/27/3226520/0/en/Propanc-Biopharma-Accelerates-IP-Momentum-Files-Fourth-Provisional-Patent-Application-in-Just-Two-Months-Strengthening-Global-Protection-for-Breakthrough-Proenzyme-Formulations.html

    GLOBENEWSWIRE
    27 Jan 2026
    Share Share
    Propanc Bio Files Patent For Trypsinogen & Chymotrypsinogen
    Propanc Bio Files Patent For Trypsinogen & Chymotrypsinogen

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221748/0/en/Propanc-Biopharma-Files-New-Provisional-Patent-Application-for-Methods-of-Producing-Trypsinogen-Chymotrypsinogen-with-IP-Australia.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    Propanc Biopharma Synthesizes Recombinant Trypsinogen & Chymotrypsinogen
    Propanc Biopharma Synthesizes Recombinant Trypsinogen & Chymotrypsinogen

    23 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220823005415/en

    BUSINESSWIRE
    23 Aug 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.